Tradestie Institutional Equity Comparison Engine · Market Close May 26, 2026

ABL vs IPOD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

ABL Overall Winner 6-Pillar Tally: ABL 5 – 0 IPOD (1 Tie) Matrix Metrics: ABL 7 – 3 IPOD

As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABL carries a Unified Composite Score of 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin), whereas IPOD carries 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABL vs IPOD
ABL NASDAQ Head-to-Head Winner
Abacus Global Management, Inc. Class A Common Stock
Investment Advice
$8.47
-0.35% 1D
Market Cap $830.9M
TTM Revenue $87M
Forward P/E 8.6x
Beta / 30D Vol 1.19β · 48% Vol
Unified Composite Score
61.3 / 100 BUY
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (13.4% over 20 days), RSI 68
RSI-14: 67.8 · SMA20: $7.89 · SMA50: $6.67
IPOD US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 2% Vol
Unified Composite Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (ABL 5 – 0 IPOD)

Columns: Metric · ABL · IPOD
1. Valuation Multiples ABL
Forward P/E 8.6x N/M
Trailing P/E N/M 39.9x
PEG Ratio N/M N/M
EV / Revenue 9.6x N/M
2. Growth & Scale ABL
Revenue Growth (YoY) +123.7% +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $87M N/A
Market Cap $830.9M $210.0M
3. Profitability & Quality ABL
Gross Margin 87.5% N/A
Operating Margin 35.6% 0.0%
Net Profit Margin 5.6% 0.0%
Return on Equity (ROE) 3.2% 0.0%
4. Balance Sheet & Cash Flow ABL
Cash Generation (TTM) $32M EBITDA N/A
Cash Flow Margin 36.7% EBITDA Mgn N/A
Net Cash / Leverage $4.45 Book/Sh · 3.2% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 52.0% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ABL
OpEx & R&D Intensity 51.9% of Rev ($45M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Life Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABL (7) vs IPOD (3)
Institutional Metric ABL IPOD Criterion Row Edge
Market Capitalization
Scale
$830.9M $210.0M Larger Scale ABL
Trailing P/E Ratio
Valuation
N/M 39.9x Lower Multiple IPOD
Forward P/E Ratio
Valuation
8.6x N/M Lower Multiple ABL
Revenue Growth (YoY)
Growth
+123.7% +0.0% Higher Growth ABL
Operating Margin (TTM)
Profitability
35.6% 0.0% Higher Margin ABL
Net Profit Margin
Profitability
5.6% 0.0% Higher Margin ABL
Return on Equity (ROE)
Capital Efficiency
3.2% 0.0% Higher ROE ABL
52-Week Range Position
Momentum
77% ($5–$10) 100% ($10–$10) Stronger Trend IPOD
Beta / 30D Volatility
Risk Regime
1.19β · 48% Vol 0.00β · 2% Vol Lower Realized Risk IPOD
Unified Institutional Score
Composite Signal
61.3 / 100 (BUY) 58.0 / 100 (HOLD) Higher Composite ABL
Trailing 12M Revenue (USD)
Operating Scale
$87M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
87.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$32M EBITDA ($4.45 Book/Sh · 3.2% ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABL +58.4 pp
ABL: +58.91% · IPOD: +0.51%
3M Horizon ABL +57.73 pp
ABL: +59.21% · IPOD: +1.48%
6M Horizon ABL +43.37 pp
ABL: +45.03% · IPOD: +1.66%
1Y Horizon ABL +43.37 pp
ABL: +45.03% · IPOD: +1.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABL vs IPOD. Trailing 12-month operating profitability (ABL 35.6% vs IPOD 0.0%) and valuation multiples (ABL 8.6x vs IPOD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ABL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$87M
Gross Margin87.5%
Op. Margin35.6%
ROE / Fwd P/E3.2% · 8.6x
IPOD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 52.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IPOD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IPOD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABL Moat Profile High-Margin Pricing Power Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with $830.9M market capitalization and 35.6% operating margin.
OpEx & R&D Reinvestment 51.9% of Rev ($45M)
90D Engineering Disclosures 0 Published
IPOD Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ABL vs IPOD Key Questions & Quantitative Answers

As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABL carries a Unified Composite Score of 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin), whereas IPOD carries 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin). Technically, ABL sits in a Markup phase (RSI 67.8, UNCLASSIFIED options structure) and IPOD sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure).

ABL leads the Growth & Scale pillar: ABL posts +123.7% YoY revenue growth and N/A YoY earnings growth on $87M TTM revenue (87.5% gross margin, 35.6% operating margin), compared with IPOD at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, ABL generates $87M in USD-normalized revenue versus N/A for IPOD. In operating R&D and SG&A reinvestment, ABL deploys 51.9% of Rev ($45M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IPOD.

ABL screens cheaper on headline valuation multiples. ABL trades at 8.6x Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (36.7% EBITDA margin), whereas IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABL (3.2% ROE) versus IPOD (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ABL carries 52.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 48% Vol realized risk). By comparison, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of May 26, 2026. For educational research only; not investment advice.